Abel Hall »

Heron Therapeutics shares owned by Abel Hall

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Abel Hall from 13F filings

Historical chart of Abel Hall investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by Abel Hall consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by Abel Hall

Quarter filed Position value Share count Share price at filing
2025-12-31 $60k 46k 1.30

More positions owned by Abel Hall

Dimensional Etf Trust Us Core Equity 2 (DFAC)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Us High Profitab (DUHP)
Dimensional Etf Trust Us Small Cap Val (DFSV)
Microsoft Corporation (MSFT)
Apple (AAPL)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Dimensional Etf Trust Intl Small Cap V (DISV)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Abel Hall

Top funds holding Heron Therapeutics

Rubric Capital Management
Clearline Capital
Adage Capital Partners GP
BlackRock
Vanguard Group
Velan Capital Investment Management
Palisade Capital Management
Tang Capital Management
Tejara Capital
Baker Bros. Advisors
Geode Capital Management
State Street Corporation
JW Asset Management
D. E. Shaw & Co
Congress Park Capital

View all funds holding Heron Therapeutics